Literature DB >> 11882044

The CD28/HLA-DR expressions on CD4+T but not CD8+T cells are significant predictors for progression to AIDS.

Byeong-Sun Choi1, Yong-Keun Park, Joo-Shil Lee.   

Abstract

To investigate the changes of CD28 and HLA-DR molecules on CD4+ and CD8+ T cells during HIV infection, we classified 130 HIV-infected Koreans into four groups by the CD4 level as follows: group I (> or = 500 cells/mm3), group II (201-499 cells/mm3), group III (51-200 cells/mm3), and group IV (< or = 50 cells/mm3). In CD4+ T cells, the proportion of CD28 expression decreased significantly with the CD4 level while the proportion of HLA-DR expression increased gradually. In particular, the changes of HLA-DR expressions on CD4+ T cells were parallel to the loss of CD28 molecules from stage III to IV. However, the CD28 expression on CD8+ T cells decreased dramatically in the early stage of HIV infection, and the sum and pattern of CD28 and HLA-DR expressions on CD8+ T cells was stable after the first stage. Even though CD28 down-regulation on CD8+ T cells was very severe from the early stage of HIV infection, it might not influence the survival time of HIV-infected Koreans. The sum of the CD28+ subsets and HLA-DR subsets in each T cell was stable in all stages of disease progression. The sums of the CD28+ subsets and HLA-DR+ subsets in CD4+ T and CD8+ T cells were constant as approximately 100% and 55-60% of each T cell. These results suggested that the changes of CD28/HLA-DR expressions on CD4+ T cells were more predictable than those on CD8+ T cells in the evaluation of the disease progression during HIV-infected periods. However, we need further studies to understand why the sum of two molecules in each T cell are constant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882044      PMCID: PMC1906297          DOI: 10.1046/j.1365-2249.2002.01732.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.

Authors:  G R Kaufmann; J J Zaunders; P Cunningham; A D Kelleher; P Grey; D Smith; A Carr; D A Cooper
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

2.  Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy.

Authors:  M Dorrucci; B Suligoi; D Serraino; U Tirelli; G Rezza
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-01       Impact factor: 3.731

3.  An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status.

Authors:  A L Landay; C E Mackewicz; J A Levy
Journal:  Clin Immunol Immunopathol       Date:  1993-10

4.  Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.

Authors:  S Suarez; L Baril; B Stankoff; M Khellaf; B Dubois; C Lubetzki; F Bricaire; J J Hauw
Journal:  AIDS       Date:  2001-01-26       Impact factor: 4.177

5.  CD28 ligation in T-cell activation: evidence for two signal transduction pathways.

Authors:  J A Ledbetter; J B Imboden; G L Schieven; L S Grosmaire; P S Rabinovitch; T Lindsten; C B Thompson; C H June
Journal:  Blood       Date:  1990-04-01       Impact factor: 22.113

6.  Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.

Authors:  A R Lifson; S P Buchbinder; H W Sheppard; A C Mawle; J C Wilber; M Stanley; C E Hart; N A Hessol; S D Holmberg
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

7.  Expansion of a CD8+CD28- cell population in the blood and lung of HIV-positive patients.

Authors:  J J Saukkonen; H Kornfeld; J S Berman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-11

8.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

9.  The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels.

Authors:  H W Sheppard; W Lang; M S Ascher; E Vittinghoff; W Winkelstein
Journal:  AIDS       Date:  1993-09       Impact factor: 4.177

10.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.

Authors:  P S Linsley; W Brady; L Grosmaire; A Aruffo; N K Damle; J A Ledbetter
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  5 in total

1.  Early immune senescence in HIV disease.

Authors:  Seema Desai; Alan Landay
Journal:  Curr HIV/AIDS Rep       Date:  2010-02       Impact factor: 5.071

2.  Low transcriptomic of PTPRCv1 and CD3E is an independent predictor of mortality in HIV and tuberculosis co-infected patient.

Authors:  Gebremedhin Gebremicael; Atsbeha Gebreegziabxier; Desta Kassa
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

3.  Premature aging of T cells is associated with faster HIV-1 disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Rita B Effros; Roger Detels
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

4.  T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ.

Authors:  Nicolás A Giraldo; Natalia I Bolaños; Adriana Cuellar; Nubia Roa; Zulma Cucunubá; Fernando Rosas; Víctor Velasco; Concepción J Puerta; John M González
Journal:  PLoS Negl Trop Dis       Date:  2013-01-31

5.  Frailty, markers of immune activation and oxidative stress in HIV infected elderly.

Authors:  Susana Álvarez; Fátima Brañas; Matilde Sánchez-Conde; Santiago Moreno; Juan Carlos López-Bernaldo de Quirós; Mª Ángeles Muñoz-Fernández
Journal:  PLoS One       Date:  2020-03-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.